| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8454589 | Lung Cancer | 2016 | 6 Pages |
Abstract
Oral etoposide monotherapy is an active option for pretreated TET patients, with manageable toxicity profile.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
M.V. Bluthgen, C. Boutros, F. Fayard, J. Remon, D. Planchard, B. Besse,